抗自身免疫性疾病主要生物制剂的研究进展

摘要

Immune system is a security guard to help human body repel or remove bacteria, viruses, parasites and other fore-ign invaders .But when some tissue components or the immune system itself become abnormal, it can not distinguish friend from foe accurately and may attack our own tissue then cause some clinical symptoms, leading to autoimmune diseases. Nearly 5 % of the world's population suffer from various autoimmune diseases. By now in addition to control the formation of autoantigens such as infection,tiredness, the main biologics used in clinic are immunoregulators to block pathological autoimmune response and then to create a new proper immune response. Recently, new biologics to treat autoimmune disease come into being one after another, and this article gives a brief overview about research progress in anti-autoimmune disease biologics.%免疫系统有助于人类排斥或清除细菌、病毒、寄生虫等外来入侵，但当机体的某些组织成分或免疫系统自身出现异常时，它就不能有效地分辨敌我，甚至攻击自身组织引起一些临床症状，形成自身免疫性疾病。全世界有近5%的人口饱受各种自身免疫病的困扰，目前比较常用的治疗方案除了控制自身抗原的形成原因如感染、劳累等外，主要采用有免疫调节功能的生物制剂来阻断病理性自身免疫应答或者建立新的正确的免疫应答。近年来，治疗自身免疫病的新型生物制剂层出不穷，本文综述了目前常用抗自身免疫性疾病的生物制剂及其研究进展。